Logo image of HAS

HASBRO INC (HAS) Stock Fundamental Analysis

NASDAQ:HAS - Nasdaq - US4180561072 - Common Stock - Currency: USD

67.55  -1.51 (-2.19%)

Fundamental Rating

5

HAS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Leisure Products industry. HAS has a medium profitability rating, but doesn't score so well on its financial health evaluation. HAS has a valuation in line with the averages, but it does not seem to be growing. HAS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

HAS had positive earnings in the past year.
In the past year HAS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: HAS reported negative net income in multiple years.
HAS had a positive operating cash flow in 4 of the past 5 years.
HAS Yearly Net Income VS EBIT VS OCF VS FCFHAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

HAS's Return On Assets of -8.87% is on the low side compared to the rest of the industry. HAS is outperformed by 66.67% of its industry peers.
The Return On Equity of HAS (-49.81%) is worse than 70.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.67%, HAS belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
HAS had an Average Return On Invested Capital over the past 3 years of 8.46%. This is in line with the industry average of 8.27%.
The 3 year average ROIC (8.46%) for HAS is below the current ROIC(9.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.87%
ROE -49.81%
ROIC 9.67%
ROA(3y)-5.44%
ROA(5y)-1.67%
ROE(3y)-39.63%
ROE(5y)-18.77%
ROIC(3y)8.46%
ROIC(5y)7.74%
HAS Yearly ROA, ROE, ROICHAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

HAS's Operating Margin of 14.92% is amongst the best of the industry. HAS outperforms 100.00% of its industry peers.
HAS's Operating Margin has improved in the last couple of years.
HAS has a better Gross Margin (59.94%) than 93.33% of its industry peers.
HAS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.92%
PM (TTM) N/A
GM 59.94%
OM growth 3Y-14.38%
OM growth 5Y2.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y2.01%
HAS Yearly Profit, Operating, Gross MarginsHAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

3

2. Health

2.1 Basic Checks

HAS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for HAS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HAS Yearly Shares OutstandingHAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
HAS Yearly Total Debt VS Total AssetsHAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.49 indicates that HAS is not a great score, but indicates only limited risk for bankruptcy at the moment.
HAS's Altman-Z score of 2.49 is in line compared to the rest of the industry. HAS outperforms 46.67% of its industry peers.
HAS has a debt to FCF ratio of 4.64. This is a neutral value as HAS would need 4.64 years to pay back of all of its debts.
With a Debt to FCF ratio value of 4.64, HAS perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
A Debt/Equity ratio of 2.69 is on the high side and indicates that HAS has dependencies on debt financing.
With a Debt to Equity ratio value of 2.69, HAS is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.69
Debt/FCF 4.64
Altman-Z 2.49
ROIC/WACC1.19
WACC8.12%
HAS Yearly LT Debt VS Equity VS FCFHAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.3 Liquidity

HAS has a Current Ratio of 1.47. This is a normal value and indicates that HAS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.47, HAS is doing worse than 76.67% of the companies in the same industry.
HAS has a Quick Ratio of 1.29. This is a normal value and indicates that HAS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of HAS (1.29) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.29
HAS Yearly Current Assets VS Current LiabilitesHAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.52% over the past year.
Measured over the past years, HAS shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.25% on average per year.
EPS 1Y (TTM)59.52%
EPS 3Y-8.34%
EPS 5Y-0.25%
EPS Q2Q%21.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-14.53%

3.2 Future

The Earnings Per Share is expected to grow by 10.94% on average over the next years. This is quite good.
HAS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.21% yearly.
EPS Next Y9.09%
EPS Next 2Y10.89%
EPS Next 3Y13.08%
EPS Next 5Y10.94%
Revenue Next Year4.09%
Revenue Next 2Y4.2%
Revenue Next 3Y5.34%
Revenue Next 5Y5.21%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HAS Yearly Revenue VS EstimatesHAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
HAS Yearly EPS VS EstimatesHAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.80, the valuation of HAS can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of HAS indicates a somewhat cheap valuation: HAS is cheaper than 70.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 30.30, HAS is valued a bit cheaper.
A Price/Forward Earnings ratio of 15.40 indicates a correct valuation of HAS.
HAS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.06, HAS is valued a bit cheaper.
Industry RankSector Rank
PE 16.8
Fwd PE 15.4
HAS Price Earnings VS Forward Price EarningsHAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

HAS's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HAS indicates a somewhat cheap valuation: HAS is cheaper than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.04
EV/EBITDA 14.4
HAS Per share dataHAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HAS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HAS's earnings are expected to grow with 13.08% in the coming years.
PEG (NY)1.85
PEG (5Y)N/A
EPS Next 2Y10.89%
EPS Next 3Y13.08%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.58%, HAS is a good candidate for dividend investing.
HAS's Dividend Yield is rather good when compared to the industry average which is at 4.10. HAS pays more dividend than 86.67% of the companies in the same industry.
HAS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 4.58%

5.2 History

The dividend of HAS has a limited annual growth rate of 2.53%.
HAS has been paying a dividend for at least 10 years, so it has a reliable track record.
HAS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.53%
Div Incr Years2
Div Non Decr Years11
HAS Yearly Dividends per shareHAS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of HAS are negative and hence is the payout ratio. HAS will probably not be able to sustain this dividend level.
The dividend of HAS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-60.71%
EPS Next 2Y10.89%
EPS Next 3Y13.08%
HAS Yearly Income VS Free CF VS DividendHAS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

HASBRO INC

NASDAQ:HAS (2/21/2025, 11:47:06 AM)

67.55

-1.51 (-2.19%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners88.2%
Inst Owner Change5.14%
Ins Owners0.52%
Ins Owner Change-0.06%
Market Cap9.42B
Analysts83.33
Price Target77.08 (14.11%)
Short Float %3.2%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield 4.58%
Yearly Dividend2.8
Dividend Growth(5Y)2.53%
DP-60.71%
Div Incr Years2
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.41%
Min EPS beat(2)34.03%
Max EPS beat(2)54.79%
EPS beat(4)3
Avg EPS beat(4)42.76%
Min EPS beat(4)-42.71%
Max EPS beat(4)124.94%
EPS beat(8)5
Avg EPS beat(8)20.18%
EPS beat(12)7
Avg EPS beat(12)16.93%
EPS beat(16)11
Avg EPS beat(16)25.08%
Revenue beat(2)1
Avg Revenue beat(2)1.2%
Min Revenue beat(2)-2.04%
Max Revenue beat(2)4.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-5.85%
Max Revenue beat(4)4.44%
Revenue beat(8)4
Avg Revenue beat(8)1%
Revenue beat(12)6
Avg Revenue beat(12)0.86%
Revenue beat(16)8
Avg Revenue beat(16)1.13%
PT rev (1m)-3.91%
PT rev (3m)-0.8%
EPS NQ rev (1m)-3.61%
EPS NQ rev (3m)-1.94%
EPS NY rev (1m)-1.1%
EPS NY rev (3m)-0.67%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 16.8
Fwd PE 15.4
P/S 2.18
P/FCF 11.04
P/OCF 8.99
P/B 7.32
P/tB N/A
EV/EBITDA 14.4
EPS(TTM)4.02
EY5.95%
EPS(NY)4.39
Fwd EY6.49%
FCF(TTM)6.12
FCFY9.06%
OCF(TTM)7.52
OCFY11.13%
SpS30.99
BVpS9.23
TBVpS-10.98
PEG (NY)1.85
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.87%
ROE -49.81%
ROCE 12.46%
ROIC 9.67%
ROICexc 12.54%
ROICexgc 42.67%
OM 14.92%
PM (TTM) N/A
GM 59.94%
FCFM 19.75%
ROA(3y)-5.44%
ROA(5y)-1.67%
ROE(3y)-39.63%
ROE(5y)-18.77%
ROIC(3y)8.46%
ROIC(5y)7.74%
ROICexc(3y)9.49%
ROICexc(5y)10.65%
ROICexgc(3y)30.59%
ROICexgc(5y)30.14%
ROCE(3y)10.98%
ROCE(5y)10.02%
ROICexcg growth 3Y-2.14%
ROICexcg growth 5Y13.8%
ROICexc growth 3Y0.56%
ROICexc growth 5Y-2.22%
OM growth 3Y-14.38%
OM growth 5Y2.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y2.01%
F-Score2
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 2.69
Debt/FCF 4.64
Debt/EBITDA 4.18
Cap/Depr 106.73%
Cap/Sales 4.51%
Interest Coverage 4.18
Cash Conversion 126.7%
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.29
Altman-Z 2.49
F-Score2
WACC8.12%
ROIC/WACC1.19
Cap/Depr(3y)73.87%
Cap/Depr(5y)68.6%
Cap/Sales(3y)3.07%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.52%
EPS 3Y-8.34%
EPS 5Y-0.25%
EPS Q2Q%21.05%
EPS Next Y9.09%
EPS Next 2Y10.89%
EPS Next 3Y13.08%
EPS Next 5Y10.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-14.53%
Revenue Next Year4.09%
Revenue Next 2Y4.2%
Revenue Next 3Y5.34%
Revenue Next 5Y5.21%
EBIT growth 1Y-9.59%
EBIT growth 3Y-16.87%
EBIT growth 5Y4.57%
EBIT Next Year49.11%
EBIT Next 3Y20.94%
EBIT Next 5Y13.85%
FCF growth 1Y280.39%
FCF growth 3Y-15.33%
FCF growth 5Y0.42%
OCF growth 1Y169.1%
OCF growth 3Y-9.42%
OCF growth 5Y2.35%